Skip to content
CG

Cresanto Global

531207 BSE
Price unavailable

Cresanto Global (CRESANTO) share price was ₹5.37 at the 21 Sep 2026 close; sector Healthcare. In the Jun 2026 quarter, revenue was under ₹1 Cr in both quarters and net profit was −₹0.06 Cr, against −₹0.09 Cr a year earlier (compared with Jun 2025). Promoters held 32.27% of Cresanto Global in Sep 2026, unchanged from Jun 2026.

Close 21 Sep 2026 ₹5.37 +1.54 +40.21% 1Y

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
EBITDA
−₹30.00 L
Return on Equity
14.26%
Debt to Equity
0
Book Value
−₹7.08
EPS (TTM)
−₹0.93

Price-based figures · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,768.2035.084,24,250 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,670.0087.772,56,708 Cr15.320.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.0072.351,75,312 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.60108.081,18,199 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.0026.281,17,805 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,339.0034.681,11,764 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,364.9032.701,10,265 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Cresanto Global (this company)
——2 Cr—0.00%14.26%128.29%0 Cr-0 Cr
Median 8 companies₹1,768.2035.081,18,002 Cr5.080.47%14.03%18.45%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Weaknesses

2
  • Company has low interest coverage ratio.
  • Promoter holding is low: 32.3%

Technical Indicators

Oscillators

Bearish

Bearish
5
Neutral
1
Bullish
3

Overall

Bullish

Bearish
5
Neutral
1
Bullish
13

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
-80%

change over 1 year

Net Income Growth
100% lower than 3Y

change over 1 year

Cash Flow Change
42.55%

change over 1 year

EBITDA Margin Change
—

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0.05
0
0
0
Expenses
0.01
0.02
0.02
0.05
0.02
0.02
0.26
0.34
0.09
0.06
0.11
0.08
0.06
Operating Profit
-0.01
-0.02
-0.02
-0.05
-0.02
-0.02
-0.26
-0.34
-0.09
-0.01
-0.11
-0.08
-0.06
OPM %
—
—
—
—
—
—
—
—
—
-20%
—
—
—
Other Income
0
0
0
0
0
0
0.01
0.52
0
0
0.02
0
0
Interest
0
0
0
0
0
0
0
0.11
0
0
0
0.16
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.01
-0.02
-0.02
-0.05
-0.02
-0.02
-0.25
0.07
-0.09
-0.01
-0.09
-0.24
-0.06
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
-0.02
-0.02
-0.02
-0.05
-0.02
-0.02
-0.25
0.07
-0.09
-0.01
-0.09
-0.24
-0.06
EPS (₹)
-0.05
-0.05
-0.05
-0.12
-0.05
-0.05
-0.59
0.16
-0.21
-0.02
-0.21
-0.56
-0.14
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
0
0
0
0
0
0
0
0.05
0.05
Expenses
0.04
0.03
0.03
0.03
0.03
0.06
0.07
0.08
0.19
0.1
0.6
0.34
0.31
Operating Profit
-0.04
-0.03
-0.03
-0.03
-0.03
-0.06
-0.07
-0.08
-0.19
-0.1
-0.6
-0.29
-0.26
OPM %
—
—
—
—
—
—
—
—
—
—
—
-580%
-520%
Other Income
0.02
0
-0.01
-0.02
-0.02
0.01
0.01
0
0.02
0
0.53
0.02
0.02
Interest
0
0
0
0
0
0
0
0
0
0
0.11
0.16
0.16
Depreciation
0
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0
0
0
0
PBT
-0.02
-0.04
-0.05
-0.06
-0.06
-0.06
-0.07
-0.09
-0.18
-0.1
-0.18
-0.43
-0.4
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Net Profit
-0.02
-0.04
-0.05
-0.06
-0.05
-0.06
-0.07
-0.08
-0.17
-0.1
-0.18
-0.43
-0.4
EPS (₹)
-0.05
-0.09
-0.12
-0.14
-0.12
-0.14
-0.16
-0.19
-0.4
-0.23
-0.42
-1.01
-0.93
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
4.27
Reserves
-6
-6.04
-6.09
-6.15
-6.2
-6.26
-6.33
-6.41
-6.58
-6.68
-6.86
-7.29
Borrowings
2
1.99
2.03
2.04
2.05
2.07
2.21
0.05
0
2.43
2.37
2.81
Other Liabilities
0.04
0.06
0.07
0.11
0.14
0.18
0.1
2.33
2.47
0.13
0.25
0.22
Total Liabilities
0.31
0.28
0.28
0.27
0.26
0.26
0.25
0.24
0.16
0.15
0.03
0.01
Fixed Assets
0.2
0.19
0.19
0.18
0.17
0.17
0.16
0.16
0.15
0.15
0
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0.11
0.09
0.09
0.09
0.09
0.09
0.09
0.08
0.01
0
0.03
0.01
Total Assets
0.31
0.28
0.28
0.27
0.26
0.26
0.25
0.24
0.16
0.15
0.03
0.01
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.03
0.01
0
0
0
0
0
-2.21
-0.16
-0.06
-0.47
-0.27
Investing
0
0
0
0
0
0
0
2.21
0.16
0.06
0.59
0.44
Financing
0.03
-0.01
0
0
0
0
0
0
0
0
-0.11
-0.16
Net Cash Flow
0
0
0
0
0
0
0
0
0
0
0
0.01
Free Cash Flow
-0.03
0.01
0
0
0
0
0
-2.21
-0.16
-0.06
0.18
-0.27
CFO/OP
75
-33
0
0
0
0
0
2,762
84
60
78
93
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
—
—
—
—
—
—
—
0
Inventory Days
—
—
—
—
—
—
—
—
—
—
—
0
Cash Conversion Cycle
—
—
—
—
—
—
—
—
—
—
—
0
Working Capital Days
—
—
—
—
—
—
—
—
—
—
—
-1,606
ROCE %
-7.84%
-8.16%
-13.95%
-16.22%
-21.43%
-60%
-60.87%
—
—
—
—
—

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Cresanto Global insights

60 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

DIIs0.96%Public44.09%Others22.68%Promot.32.27%As ofSep 2026

Documents

Frequently Asked Questions about Cresanto Global

What does Cresanto Global Limited do?
Incorporated in 1994, Cresanto Global Ltd is in the business of flexible packaging and trading business.[1]
Where is Cresanto Global Limited (CRESANTO) listed?
Cresanto Global Limited trades under code 531207 on the BSE.
Which sector does Cresanto Global Limited belong to?
Cresanto Global Limited is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the Return on Equity (ROE) of Cresanto Global Limited?
Cresanto Global Limited reported a return on equity of 14.26%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1994, Cresanto Global Ltd is in the business of flexible packaging and trading business.[1]

Website raymedlabs.com
Listed 2011-07-19
Face Value ₹ 10
Shares Outstanding 42,83,054

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531207.md for Cresanto Global Limited: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month